ACE2 and infection: Consistent with the low expression levels of ACE2 in human pulmonary and bronchial epithelial cells, downregulation of ACE2 elicited a minor effect with regard to reducing SARS-CoV-2 virus pseudotype infection of H1299 cells, indicating that ACE2 might not be a good drug target for the lungs and bronchi.